YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
Novartis AG penned a $9.7 billion purchase deal for Medicines Co.
Bloomberg reports the acquisition focuses mostly on a single treatment: experimental cholesterol drug inclisiran.
Similarly, last year Novartis gained muscle disease gene therapy Zolgensma by buying drugmaker AveXis Inc. for $8.7 billion.
Read more from Bloomberg.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Eric Schmitt introduces Modern Skies Act
Caterpillar to acquire John Fabick Tractor Co.
Springfield airport to cut the ribbon on $35M in construction projects
Legacy Bank accused in lawsuit of failing to protect customers in data breach